Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible TuberculosisPayam Nahid, Andrew Vernon, Charles A. Peloquin et al.|Clinical Infectious Diseases|2016Cited by 1.5k
Four-Month Rifapentine Regimens with or without Moxifloxacin for TuberculosisSusan E. Dorman, Richard E. Chaisson, Payam Nahid et al.|New England Journal of Medicine|2021Cited by 548
Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studiesNarges Alipanah, Payam Nahid|PLoS Medicine|2018Cited by 506
Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible TuberculosisPayam Nahid, Andrew Vernon, Susan E. Dorman et al.|Clinical Infectious Diseases|2016Cited by 321
Daily Rifapentine for Treatment of Pulmonary Tuberculosis. A Randomized, Dose-Ranging TrialSusan E. Dorman, Marc Weiner, Radojka M. Savić et al.|American Journal of Respiratory and Critical Care Medicine|2014Cited by 112